Medicine recalls
|
| |
| Canada: Jamp-Rabeprazole 10mg & 20mg: Affected lot contains overweight or underweight Delayed-Release tablets |
| |
Health Canada announces that JAMP Pharma Corporation is recalling the following products from wholesalers, retailers and healthcare establishments because the affected lots contain overweight or underweight Delayed-Release tablets:
- Jamp-Rabeprazole 10mg Tablet (delayed release) (lot number: EG24RJA002)
- Jamp-Rabeprazole 20mg Tablet (delayed release) (lot number: EG23RJC003, EG23RJC006, EG23RJC007, EG23RJC009, EG23RJC010, EG23RJD001, EG23RJD002, EG23RJD003, EG23RJD004, EG24RJD001)
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/jamp-rabeprazol-10mg-20mg-affected-lot-contains-overweight-or-underweight-delayed
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 8 Aug 2024.
Ends/Thursday, Aug 22, 2024
Issued at HKT 16:00
|
| |
|
